PSP94 (prostate secretory protein of 94 amino acids) was regarded as a possible prostate cancer marker, however, it has been controversial. All prior studies were designed to test the free form in serum using antibodies to PSP94. Results presented here demonstrate that PSP94 exists in prostate cance
Prostatic cancer. VII. Serum acid phosphatase response to cholinergic stimulation in prostatic cancer patients
โ Scribed by Perry B. Hudson; Manuel Ty Jr.
- Publisher
- John Wiley and Sons
- Year
- 1958
- Tongue
- English
- Weight
- 244 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Disseminated intravascular coagulation (dic) and primary fibrinolysis have both been reported in association with prostate carcinoma. the correct diagnosis of the coagulopathy can be difficult and the appropriate management controversial. ## Methods: A case is presented of a man in
## BACKGROUND. Our purpose was to compare the importance of over 22 measurements used in evaluating the clinical responses of patients with metastatic or locally recurrent prostate cancer, treated by dendritic cell (DC) infusions with prostate-specific membrane antigen (PSMA) peptides. METHODS. Art
BACKGROUND. Metastatic prostate cancer clinical evaluation is difficult. A revaluation of new prostate markers with regard to bone scans was performed. METHODS. Serial markers, including bone alkaline phosphatase (BAP), total alkaline phosphatase (TAP), prostate-specific antigen, total (PSA) and fre